Kerala Ayurveda Ltd

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Kerala Ayurveda Ltd’s shares touched a fresh 52-week low of Rs.161.05 today, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. Despite a volatile trading session, the stock remains below all key moving averages, reflecting persistent downward momentum.

Kerala Ayurveda Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.162 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and market performance.

Kerala Ayurveda Ltd’s shares fell sharply to a new 52-week low of Rs.163.7 on 13 Mar 2026, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its peers and broader market indices, reflecting persistent financial and market challenges.

Kerala Ayurveda Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.180 today, marking a significant decline amid ongoing market pressures and company-specific headwinds. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial and technical performance.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 March 2026, providing investors with the latest insights into the stock’s performance and fundamentals.

Kerala Ayurveda Ltd’s shares have declined to a fresh 52-week low of Rs.194, marking a significant downturn for the Pharmaceuticals & Biotechnology company. The stock has been under pressure for several sessions, reflecting ongoing concerns about its financial health and market performance.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Kerala Ayurveda Ltd’s shares declined to a fresh 52-week low of Rs.196.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s financial performance and market valuation within the Pharmaceuticals & Biotechnology sector.

Kerala Ayurveda Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.210 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing financial pressures and subdued performance metrics.

Kerala Ayurveda Ltd’s shares touched a fresh 52-week low of Rs.213.3 today, marking a significant decline amid a sustained downtrend. The stock has underperformed its sector and broader market indices, reflecting ongoing financial pressures and subdued performance metrics.

Kerala Ayurveda Ltd’s shares have declined to a fresh 52-week low of Rs.215.15, marking a significant downturn for the Pharmaceuticals & Biotechnology company as it continues to underperform the broader market and its sector peers.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 August 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 16 February 2026, providing investors with the latest insights into its performance and prospects.

Kerala Ayurveda Ltd., a micro-cap ayurvedic products manufacturer with a market capitalisation of ₹292.00 crores, posted a consolidated net loss of ₹4.45 crores in Q3 FY26 (October-December 2025), marking a deterioration of 53.98% year-on-year compared to a loss of ₹2.89 crores in Q3 FY25. The loss deepened sequentially by 29.81% from the previous quarter's loss of ₹6.34 crores, extending a troubling pattern of persistent unprofitability despite modest topline growth.

Kerala Ayurveda Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 February 2026, providing investors with the latest insights into the stock’s performance and outlook.

Kerala Ayurveda Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.230.1 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind sector peers and broader market indices, reflecting ongoing pressures on the company’s financial metrics and market sentiment.